Health & BeautyNews
Bridgepoint to acquire RoC Skincare
The strategic investment in RoC builds on the firm’s growing track record of supporting businesses in the wider dermatology ecosystem, including HTL, a leading producer of high-quality hyaluronic acid, and Vivacy, a global personal healthcare company
![](https://b855165.smushcdn.com/855165/wp-content/uploads/2024/01/Screenshot-2024-01-24-at-10.07.09 am-895x540.png?lossy=1&strip=1&webp=1)
Bridgepoint has announced a strategic investment in RoC Skincare (RoC) from the brand’s existing backer, Gryphon Investors for an undisclosed amount.
You'll need to
subscribe to unlock this content. Already subscribed? Login?